Early Tranexamic Acid Administration After Traumatic Brain Injury Is Associated With Reduced Syndecan-1 and Angiopoietin-2 in Patients With Traumatic Intracranial Hemorrhage
暂无分享,去创建一个
[1] H. Mizuguchi,et al. Angiopoietin‐1/Tie‐2 signal after focal traumatic brain injury is potentiated by BQ788, an ETB receptor antagonist, in the mouse cerebrum: Involvement in recovery of blood–brain barrier function , 2020, Journal of neurochemistry.
[2] R. Matthews,et al. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial , 2019, The Lancet.
[3] J. Maguire,et al. The effect of angiopoietin-1 upregulation on the outcome of acute ischaemic stroke in rodent models: A meta-analysis , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] M. S. Sajib,et al. Role of Angiopoietin-2 in Vascular Physiology and Pathophysiology , 2019, Cells.
[5] G. Leung,et al. Improving Survival with Tranexamic Acid in Cerebral Contusions or Traumatic Subarachnoid Hemorrhage: Univariate and Multivariate Analysis of Independent Factors Associated with Lower Mortality. , 2019, World neurosurgery.
[6] Eric P. Schmidt,et al. The glycocalyx: a novel diagnostic and therapeutic target in sepsis , 2019, Critical Care.
[7] A. Mukhopadhyay,et al. Acute Traumatic Endotheliopathy in Isolated Severe Brain Injury and Its Impact on Clinical Outcome , 2018, Medical sciences.
[8] C. Wade,et al. Syndecan-1: A Quantitative Marker for the Endotheliopathy of Trauma. , 2017, Journal of the American College of Surgeons.
[9] K. Alitalo,et al. Therapeutic targeting of the angiopoietin–TIE pathway , 2017, Nature Reviews Drug Discovery.
[10] S. Kushimoto,et al. Effectiveness of early administration of tranexamic acid in patients with severe trauma , 2017, The British journal of surgery.
[11] Likang Xu,et al. Traumatic Brain Injury–Related Emergency Department Visits, Hospitalizations, and Deaths — United States, 2007 and 2013 , 2017, Morbidity and mortality weekly report. Surveillance summaries.
[12] V. Rahimi-Movaghar,et al. The effect of tranexamic acid in traumatic brain injury: A randomized controlled trial , 2017, Chinese journal of traumatology = Zhonghua chuang shang za zhi.
[13] F. Logerfo,et al. Intraluminal delivery of thrombospondin‐2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] F. Logerfo,et al. Intraluminal delivery of thrombospondin-2 small interfering RNA inhibits the vascular response to injury in a rat carotid balloon angioplasty model. , 2017 .
[15] H. Gu,et al. Angiopoietin-1 and Angiopoietin-2 Expression Imbalance Influence in Early Period After Subarachnoid Hemorrhage , 2016, International neurourology journal.
[16] Kechen Ban,et al. Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock , 2016, The journal of trauma and acute care surgery.
[17] S. Zehtabchi,et al. Tranexamic acid for traumatic brain injury: a systematic review and meta-analysis. , 2014, The American journal of emergency medicine.
[18] D. Menon,et al. Endothelial Activation and Chemoattractant Expression are Early Processes in Isolated Blast Brain Injury , 2014, NeuroMolecular Medicine.
[19] L. Kubala,et al. Modulation of Endothelial Glycocalyx Structure under Inflammatory Conditions , 2014, Mediators of inflammation.
[20] L. Rasmussen,et al. Assessment of coagulopathy, endothelial injury, and inflammation after traumatic brain injury and hemorrhage in a porcine model , 2014, The journal of trauma and acute care surgery.
[21] C. Guerriero,et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. , 2013, Health technology assessment.
[22] L. Rasmussen,et al. Trauma-induced coagulopathy: standard coagulation tests, biomarkers of coagulopathy, and endothelial damage in patients with traumatic brain injury. , 2013, Journal of neurotrauma.
[23] Qi-dong Yang,et al. Thrombin promotes the expression of thrombospondin-1 and ‐2 in a rat model of intracerebral hemorrhage , 2012, Journal of the Neurological Sciences.
[24] S. Ostrowski,et al. Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy , 2012, The journal of trauma and acute care surgery.
[25] Jin Lei,et al. Is management of acute traumatic brain injury effective? A literature review of published Cochrane Systematic Reviews. , 2012, Chinese journal of traumatology = Zhonghua chuang shang za zhi.
[26] J. Holcomb,et al. Modulation of Syndecan-1 Shedding after Hemorrhagic Shock and Resuscitation , 2011, PloS one.
[27] T. Kyriakides,et al. Astrocyte-derived thrombospondin-2 is critical for the repair of the blood-brain barrier. , 2011, The American journal of pathology.
[28] J. Montaner,et al. A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke. , 2011, Atherosclerosis.
[29] Qi-dong Yang,et al. Alteration of thrombospondin-1 and -2 in rat brains following experimental intracerebral hemorrhage. Laboratory investigation. , 2010, Journal of neurosurgery.
[30] J. Rafols,et al. Differential expression of capillary VEGF isoforms following traumatic brain injury , 2007, Neurological research.
[31] J. Rafols,et al. Endothelial cell activation following moderate traumatic brain injury , 2001, Neurological research.
[32] J. Boldt,et al. Changes of the hemostatic network in critically ill patients‐Is there a difference between sepsis, trauma, and neurosurgery patients? , 2000, Critical care medicine.
[33] L. Diebel,et al. The temporal response and mechanism of action of tranexamic acid in endothelial glycocalyx degradation , 2018, The journal of trauma and acute care surgery.
[34] Yan Gao,et al. Altered expression of thrombospondin-1/-2 in the cortex and synaptophysin in the hippocampus after middle cerebral artery occlusion and reperfusion. , 2018, International journal of clinical and experimental pathology.
[35] K. Asadollahi,et al. Correlation of Homocysteine with Cerebral Hemodynamic Abnormality, Endothelial Dysfunction Markers, and Cognition Impairment in Patients with Traumatic Brain Injury. , 2017, World neurosurgery.
[36] R. Hausmann,et al. The time course of the vascular response to human brain injury – an immunohistochemical study , 2000, International Journal of Legal Medicine.